Mean plasma glucose is the average level of sugar in your blood over a period of time, typically two to three months. It’s most commonly estimated from your A1C blood test result and reported as “estimated average glucose” (eAG) on lab reports. While a single blood sugar reading is a snapshot of one moment, mean plasma glucose gives you and your doctor a bigger picture of how well your blood sugar has been controlled overall.
How Mean Plasma Glucose Is Calculated
The most widely used method ties your A1C percentage to an average blood sugar number. A1C measures how much glucose has attached to your red blood cells over their roughly three-month lifespan. From that percentage, a straightforward formula converts A1C into an estimated average glucose in the same units your home meter uses (mg/dL):
Estimated average glucose (mg/dL) = (A1C × 28.7) − 46.7
So if your A1C comes back at 7%, your estimated mean plasma glucose is about 154 mg/dL. At 6%, it’s around 126 mg/dL. This formula comes from a large international study that combined continuous glucose monitor data with frequent fingerstick readings to map A1C values onto real-world blood sugar averages. The relationship held consistently across different ages, genders, ethnicities, and diabetes types.
The reason labs report eAG alongside A1C is simple: most people are used to seeing their blood sugar as a number in mg/dL on their home meter. Telling someone their A1C is 8% is less immediately useful than telling them their average blood sugar has been running around 183 mg/dL.
What the Numbers Mean
For someone without diabetes, a normal fasting blood glucose falls between 70 and 99 mg/dL. A fasting level of 100 to 125 mg/dL generally signals prediabetes, and 126 mg/dL or higher on repeated tests points to diabetes. These are single-point fasting values, not averages, but they provide useful context for understanding where your mean glucose sits.
Mean plasma glucose captures more than fasting numbers alone. It reflects the spikes after meals, the dips overnight, and everything in between. A person with a normal fasting glucose could still have a high mean glucose if their blood sugar surges significantly after eating. That’s part of what makes average glucose a more complete measure of metabolic health than any single reading.
Why Average Glucose Matters for Health
Sustained high average glucose is what drives complications over time. Hospital research shows that patients with an average blood glucose above 140 mg/dL face meaningfully higher risks of infection, cardiovascular events, longer hospital stays, and higher mortality. In one study, patients whose glucose averaged 126 to 160 mg/dL had a 46% higher relative risk of serious complications compared to those below that range. For patients averaging above 160 mg/dL, that risk nearly doubled.
These findings apply beyond the hospital. Chronically elevated mean glucose damages small blood vessels in the eyes, kidneys, and nerves, and contributes to larger-vessel problems like heart disease and stroke. Bringing your average glucose closer to normal range is the central goal of diabetes management, and tracking mean glucose over time is how you and your doctor gauge whether that’s happening.
CGM vs. Fingersticks vs. A1C
There are three main ways to arrive at a mean glucose value, and each one captures something slightly different.
- A1C blood test: Reflects roughly three months of glucose exposure. It correlates well with mean blood glucose but smooths over the highs and lows. A person with wild swings and a person with steady levels can have the same A1C.
- Fingerstick averages: Your meter may calculate an average from stored readings. This number depends entirely on when and how often you test. If you mostly check before meals, your average will skew lower than your true all-day mean.
- Continuous glucose monitor (CGM): A sensor under the skin reads glucose in the fluid between your cells every few minutes, producing hundreds of data points per day. The mean glucose from a CGM is the most detailed average available, and it captures post-meal spikes and overnight patterns that fingersticks miss.
One subtlety worth knowing: CGMs measure glucose in interstitial fluid, not directly in blood. Plasma glucose values run about 11% higher than whole blood glucose when red blood cell counts are normal. Most modern meters and CGMs are already calibrated to report plasma-equivalent values, so the numbers are comparable, but small discrepancies between devices are common and normal.
GMI: The CGM Version of eAG
If you use a continuous glucose monitor, your reports likely include a metric called the Glucose Management Indicator (GMI). This is essentially the CGM’s version of an estimated A1C, derived from your sensor’s mean glucose using a population-based formula. Think of it as working the A1C-to-eAG conversion in reverse: the CGM knows your average glucose and estimates what your A1C would be.
GMI and your lab A1C won’t always match perfectly. A1C is measured from glucose bound to hemoglobin in your blood, while GMI comes from interstitial fluid readings. Conditions that affect red blood cell turnover, such as anemia or recent blood loss, can shift A1C without changing your actual glucose levels. When the two numbers disagree, your doctor may lean more heavily on one or the other depending on your specific situation. A persistent gap between GMI and A1C is worth discussing, because it can change how your treatment is adjusted.
Putting the Number to Use
If you see “eAG” or “mean glucose” on a lab report or CGM summary, here is a quick reference for context:
- Below 114 mg/dL (A1C under 5.7%): Normal range for someone without diabetes.
- 114 to 140 mg/dL (A1C 5.7% to 6.4%): Prediabetes range, where lifestyle changes can often prevent progression.
- Above 140 mg/dL (A1C 6.5% or higher): Diabetes range, where ongoing management is needed to reduce complication risk.
Tracking your mean plasma glucose over successive lab visits or CGM reports is one of the clearest ways to see whether your blood sugar management is improving, stable, or drifting in the wrong direction. A single elevated reading matters far less than the trend in your average over months. That average, more than any individual number, is what shapes your long-term health outcomes.